ATE349427T1 - Tryptaseinhibitoren - Google Patents
TryptaseinhibitorenInfo
- Publication number
- ATE349427T1 ATE349427T1 AT02722097T AT02722097T ATE349427T1 AT E349427 T1 ATE349427 T1 AT E349427T1 AT 02722097 T AT02722097 T AT 02722097T AT 02722097 T AT02722097 T AT 02722097T AT E349427 T1 ATE349427 T1 AT E349427T1
- Authority
- AT
- Austria
- Prior art keywords
- tryptase inhibitors
- inhibitors
- compounds
- formula
- tryptase
- Prior art date
Links
- 239000002750 tryptase inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Medicinal Preparation (AREA)
- Luminescent Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01104109 | 2001-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE349427T1 true ATE349427T1 (de) | 2007-01-15 |
Family
ID=8176550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02722097T ATE349427T1 (de) | 2001-02-21 | 2002-02-19 | Tryptaseinhibitoren |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7060716B2 (de) |
| EP (1) | EP1368317B1 (de) |
| JP (1) | JP2004518736A (de) |
| AT (1) | ATE349427T1 (de) |
| AU (1) | AU2002253035B8 (de) |
| CA (1) | CA2438685A1 (de) |
| DE (1) | DE60217076T2 (de) |
| ES (1) | ES2278913T3 (de) |
| WO (1) | WO2002066430A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2278928T3 (es) | 2001-06-19 | 2007-08-16 | Altana Pharma Ag | Inhibidores de triptasa. |
| CN105209435B (zh) * | 2013-05-14 | 2018-02-02 | 3M创新有限公司 | 包含吡啶或吡嗪的化合物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995032945A1 (en) | 1994-06-01 | 1995-12-07 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell mediated conditions |
| KR970706267A (ko) | 1994-09-23 | 1997-11-03 | 다니엘 에이치. 페트리 | 비만 세포 염증성 질환 치료용 조성물 및 방법(compositions and methods for treating mast-cell inflammatory condition) |
| AU733621B2 (en) | 1996-07-30 | 2001-05-17 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions for treating diseases associated with tryptase activity |
| AU8997498A (en) | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
| US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| EP1030844A1 (de) | 1997-11-10 | 2000-08-30 | Array Biopharma Inc. | Verbindungen, die die aktivität von tryptase hemmen |
| ES2233025T3 (es) | 1998-02-06 | 2005-06-01 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Agente inhibidores de la triptasa. |
| EP1060171A2 (de) | 1998-02-06 | 2000-12-20 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tryptase-inhibitoren |
| DE19851299A1 (de) * | 1998-02-06 | 1999-08-12 | Max Planck Gesellschaft | Tryptase-Inhibitoren |
| WO2000014097A2 (de) | 1998-09-04 | 2000-03-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue pyranosen |
| JP2003506442A (ja) | 1999-08-10 | 2003-02-18 | アルタナ ファルマ アクチエンゲゼルシャフト | 新規トリプターゼインヒビター |
| DE19937721A1 (de) | 1999-08-10 | 2001-02-15 | Max Planck Gesellschaft | Neue Diketopiperazine |
| JP2003509417A (ja) | 1999-09-14 | 2003-03-11 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
| TR200402322T4 (tr) | 1999-12-20 | 2004-12-21 | Altana Pharma Ag | Triptaz inhibitörler |
| JP2003518087A (ja) | 1999-12-20 | 2003-06-03 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
-
2002
- 2002-02-19 JP JP2002565947A patent/JP2004518736A/ja active Pending
- 2002-02-19 DE DE60217076T patent/DE60217076T2/de not_active Expired - Fee Related
- 2002-02-19 ES ES02722097T patent/ES2278913T3/es not_active Expired - Lifetime
- 2002-02-19 CA CA002438685A patent/CA2438685A1/en not_active Abandoned
- 2002-02-19 US US10/468,216 patent/US7060716B2/en not_active Expired - Fee Related
- 2002-02-19 AU AU2002253035A patent/AU2002253035B8/en not_active Ceased
- 2002-02-19 AT AT02722097T patent/ATE349427T1/de not_active IP Right Cessation
- 2002-02-19 WO PCT/EP2002/001723 patent/WO2002066430A1/en not_active Ceased
- 2002-02-19 EP EP02722097A patent/EP1368317B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2278913T3 (es) | 2007-08-16 |
| US20040067943A1 (en) | 2004-04-08 |
| US7060716B2 (en) | 2006-06-13 |
| CA2438685A1 (en) | 2002-08-29 |
| DE60217076T2 (de) | 2007-06-21 |
| AU2002253035B2 (en) | 2007-08-23 |
| EP1368317A1 (de) | 2003-12-10 |
| JP2004518736A (ja) | 2004-06-24 |
| WO2002066430A1 (en) | 2002-08-29 |
| AU2002253035B8 (en) | 2008-02-21 |
| DE60217076D1 (en) | 2007-02-08 |
| EP1368317B1 (de) | 2006-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU27304A (sh) | Novi dihidropteridinoni, postupak za njihovo dobijanje i njihova primena kao lekova | |
| ATE228111T1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
| NO20034660D0 (no) | Spiropyrazolforbindelser | |
| BR0111451A (pt) | Inibidores de serina protease | |
| NO20041493L (no) | Kjemiske forbindelser. | |
| ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
| SE0100903D0 (sv) | Compounds | |
| SE0004245D0 (sv) | Novel compounds and their use | |
| ATE372767T1 (de) | Dpp-iv-hemmer | |
| DE50202504D1 (de) | Neue 4-aminofuropyrimidine und ihre verwendung | |
| ATE275544T1 (de) | Serinprotease-inhibitoren | |
| SE0103710D0 (sv) | Compounds | |
| EP1667976A4 (de) | Isochinolinon-kaliumkanalinhibitoren | |
| ATE287403T1 (de) | 6-phenylbenzonaphthyidine | |
| DK1204659T3 (da) | Serotonerge benzofuraner | |
| DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
| ATE269313T1 (de) | Tryptase-inhibitoren | |
| DK1244614T3 (da) | Tryptase-inhibitorer | |
| DE60217076D1 (en) | Tryptaseinhibitoren | |
| ATE343390T1 (de) | Kalzilytische verbindungen | |
| ATE364037T1 (de) | Tryptasehemmer | |
| ATE348803T1 (de) | Tryptase-inhibitoren | |
| NO20024679D0 (no) | Krystallinsk farmasöytikum | |
| DK1521752T3 (da) | Makrocykliske forbindelser til behandling af cancer | |
| DK1358182T3 (da) | Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |